Karakteristik Central Serous Chorioretinopathy di Pusat Mata Nasional Rumah Sakit Mata Cicendo Tahun 2016
DOI:
https://doi.org/10.18196/mmjkk.v17i1.3680Keywords:
Central serous chorioretinopathy, serous detachment, optical coherrence tomography, angiography OCT, enhanced-depth imaging, ablasi serosa, OCT angiography enhanced-depth imagingAbstract
Central serous chorioretinopathy (CSC) merupakan penyakit pada retina yang ditandai oleh terjadinya ablasi serosa dari lapisan neurosensori retina yang diakibatkan oleh gangguan pada lapisan retinal pigmen epithelium (RPE). CSC kebanyakan terjadi pada usia pertengahan dan lebih sering terjadi pada pria dibanding wanita. Gejala utama adalah penglihatan kabur, biasanya terjadi pada satu mata dan dirasakan pasien sebagai bayangan hitam yang menghalangi penglihatan yang berhubungan dengan mikropsia atau metamorfsia. Tujuan penelitian ini untuk mendapatkan gambaran mengenai karakteristik pasien yang terdiagnosis CSC dan jenis terapi yang diberikan di Pusat Mata Nasional Rumah Sakit Mata Cicendo, pada periode Januari 2016 – Desember 2016. Penelitian dilakukan menggunakan metode deskriptif dengan desain hospital based study. Populasi penelitian ini adalah semua pasien berobat di poli mata Rumah Sakit Mata Cicendo selama periode penelitian. Data yang dikumpulkan adalah data sekunder yang diperoleh dari status pasien yang terdiagnosis CSC. Karakteristik pasien CSC yang didapatkan paling banyak adalah laki-laki (71,97%), usia 40-49 tahun (43,18%), dengan visus awal saat kedatangan pada rentang 0,4 logMAR - 0,1 logMAR (53,57%). Keterlibatan mata terbanyak bersifat unilateral (93,93%), dengan rerata ketebalan subfovea sentralis saat kedatangan adalah 402,33μm.References
Von Graefe A. Ueber Central Recidivierende Retinitis. Graefes Arch Clin Exp Ophthalmol 1866; 12: 211-5
Maria Wang, Inger Munch, Pascal W Hasler, Christian Prunte, Michael Larsen. Central Serous Chorioretinopathy. Acta Ophthalmol 2008; 86; 126-45
Ross A, Ross AH, Mohammed Q. Review and Update of Central Serous Chorioretinopathy. Curr Opin Ophthalmol 2011; 22 (3): 166-73
Wang MS, Sander B, Larsen M. Retinal Atrophy in Idiopathic Central Serous Chorioretinopathy. Am J Ophthamol 2002; 133: 787-793
Piccolino FC, de la Longrais RR, Ravera G, Eandi CM, Ventre L, Abdollahi A. The Foveal Photoreceptor Layer and Visual Acuity Loss in Central Serous Chorioretinopathy. Am J Ophthalmol 2005; 139: 87-99
David T Liu, Andrew C Fok, Waiman Chan, Timothy Y Lai, Dennis S Lam. Central Serous Chorioretinopathy. Retina 2013; 72: 1291-1303
Bujarborua D, Nagpal PN, Deka M. Smokestack Leak in Central Serous Chorioretinopathy. Graefes Aerch Clin Exp Ophthalmol 2010; 248: 33951
Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al. Optical Coherence Tomography. Science 1991; 254: 1178-81
Hee MR, Puliafito CA, Wong C, Reichel E, Duker JS, Schuman JS, et al. Optical Coherence Tomography of Central Serous Chorioretinopathy. Am J Ophthalmol 1995; 120: 65-74
Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous Chorioretinopathy: Update on Pathophysiology and Treatment. Surv Ophthalmol 2013; 58: 103-26
Errera MH, Kohly RP, Cruz L. Pregnancy Associated Retinal Diseases and Their Management. Surv Ophthalmol 2013; 58; 127-42
Eom Y, Oh J, Kim SW, Huh K. Systemic Factors Associated with Central Serous Chorioretinopathy in Koreans. Korean J Ophthalmol 2012; 26: 260-4
Aamir A, Bisma I, Hina K, Maha A. Choroidal Thickness in Both Eyes of Patients with Unilateral Central Serous Chorioretinopathy. Adv Ophthalmol Vis Syst 2016; 4: 1-5
Yanuzzi LA. Central Serous Chorioretinopathy: A Personal Perspective. Am J Ophthalmol 2010; 149: 361-3
Aggio FB, Roisman L, Melo GB, Lavinsky D, Cardillo JA, Farah ME. Clinical Factors Related to Visual Outcome in Central Serous Chorioretinopathy. Retina 2010; 30: 1128-34
Gass JD. Pathogenesis of Disciform Detachment of the Neuroepithelium. Am J Ophthalmol 1976; 63: 1-139
Bae SH, Heo JW, Kim TW, Lee JY, Song SJ, Park TK, et al. Randomized Pilot Study of LowFluence Photo Dinamic Therapy Versus Intravitreal Ranibizumab for Chronic Central Serous Chorioretinopathy. Am J Ophthalmol 2011; 152: 784-92
Schaal KB, Hoeh AE, Scheuerle A, Schuett F, Dithmar S. Intravitreal Bevacizumab for Treatment of Chronic Central Serous Chorioretinopathy. Eur J Ophthalmol 2009; 19: 613-7
Lim SJ, Roh MI, Kwon OW. Intravitreal Bevacizumab Injection for Central Serous Chorioretinopathy. Retina 2010; 39: 100-16
Downloads
Issue
Section
License
Copyright
Authors retain copyright and grant Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) the right of first publication with the work simultaneously licensed under an Attribution 4.0 International (CC BY 4.0) that allows others to remix, adapt and build upon the work with an acknowledgment of the work's authorship and of the initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
Authors are permitted to copy and redistribute the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
License
Articles published in the Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) are licensed under an Attribution 4.0 International (CC BY 4.0) license. You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
This license is acceptable for Free Cultural Works. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.